A Johnson & Johnson CAR-T therapy is now funded in Australia, almost exactly three years to the day after Health Minister Mark Butler acknowledged in response to questions about its availability that the country's use of health technology assessment is 'clunky' and responsible for preventable deaths. …
Therapy funded three years after the 'clunky' and 'preventable deaths' admission
May 5, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
La Trobe launches REACH program to fight antimicrobial resistance
May 6, 2026 - - Latest News -
If the imperative is international comparison, why limit it to these definitions?
May 5, 2026 - - Latest News -
Therapy funded three years after the 'clunky' and 'preventable deaths' admission
May 5, 2026 - - Latest News -
Time to make this 'targeted' consultation a little less targeted
May 5, 2026 - - Latest News -
Australia approves first in class therapy for chronic graft versus host disease
May 5, 2026 - - Latest News -
Lilly therapy approved in Australia as first non-covalent BTK inhibitor for common blood cancer
May 5, 2026 - - Latest News -
Medicines Australia calls for transparency, highlighting the risk of bias
May 5, 2026 - - Latest News